Archives
Carbenoxolone Disodium: Product Overview
Carbenoxolone disodium is listed by APExBIO as SKU A8389. The product information identifies it as a solid compound with molecular formula C34H48Na2O7, molecular weight 614.72, and typical stated purity of at least 98%.
Documented conceptual scope
The supplier describes carbenoxolone disodium as an 11β-hydroxysteroid dehydrogenase inhibitor associated with research on glucocorticoid access and corticosterone metabolism in tissues including the liver, kidney, pituitary, hippocampus, hypothalamus, and amygdala. The listing also associates the compound with gap junction communication and Cx43 modulation through a protein kinase A-dependent pathway.
The product description further mentions physiological associations such as hypokalemia and hypernatremia following 11β-hydroxysteroid dehydrogenase inhibition. These statements are presented here as catalog-described scope, not as independently verified outcomes.
Evidence limitations
- No matched paper evidence was supplied for this product overview.
- Therefore, the available information does not establish experimental performance, selectivity, off-target activity, or reproducibility in a defined model.
- It also does not establish suitability for apoptosis research, a neurodegenerative disease model, or glucocorticoid receptor regulation beyond the supplier’s broad conceptual description.
- The information does not support clinical interpretation or practical recommendations.